Arenicin-1 vs Davunetide
Head-to-head comparison of Arenicin-1 (Arenicin-1) and Davunetide (Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ)) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | Arenicin-1 | Davunetide |
|---|---|---|
| Category | Marine-Derived | Cognitive Enhancement |
| Full Name | Arenicin-1 | Activity-Dependent Neuroprotective Protein fragment NAP (NAPVSIPQ) |
| Molecular Weight | 2079 Da | 796.9 Da |
| Half-Life | n/a | short; minutes to low hours |
| Amino Acids | 21 | 8 |
| Typical Dose | n/a | 1-10 mg/day research range |
| Route | preclinical | Intranasal |
| Purity | ≥98% | ≥98% |
| Studies Count | 76 | 40 |
| Research Status | Pre-clinical | Clinical/Pre-clinical |
Arenicin-1 Benefits
- ✓antimicrobial
- ✓anti-biofilm
- ✓membrane-active
Davunetide Benefits
- ✓neuroprotection
- ✓microtubule support
- ✓attention support
- ✓memory preservation
Arenicin-1 Dosing
bacterial infection|biofilm disruption
Davunetide Dosing
intranasal research dosing|1-10 mg per dose in trials/preclinical work|once or twice daily
Arenicin-1 Side Effects
- ⚠Arenicola marina
Davunetide Side Effects
- ⚠nasal irritation
- ⚠headache
- ⚠limited efficacy in late-stage trials
Research Overview
Arenicin-1
Marine annelid peptide with strong preclinical antibacterial activity and a stable structural motif that is useful for peptide engineering.
Davunetide
Preclinical work showed davunetide can protect neurons, preserve synaptic structure, and improve performance in memory tasks. Human trials largely focused on neurodegenerative disease outcomes rather than stand-alone nootropic use, but the literature supports CNS activity.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.